Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter PD-L1 Antikörper (C-Term)

PD-L1 Reaktivität: Human WB, IHC, IP, IF (p), IF/ICC, mIF Wirt: Kaninchen Monoclonal BLR020E unconjugated Recombinant Antibody
Produktnummer ABIN7454042
  • Target Alle PD-L1 Antikörper anzeigen
    PD-L1 (CD274 (PD-L1))
    Antikörpertyp
    Recombinant Antibody
    Bindungsspezifität
    • 29
    • 16
    • 15
    • 11
    • 11
    • 9
    • 8
    • 7
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 163
    • 107
    • 63
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    Human
    Wirt
    • 124
    • 58
    • 17
    • 4
    • 2
    • 1
    Kaninchen
    Klonalität
    • 108
    • 96
    • 2
    Monoklonal
    Konjugat
    • 91
    • 15
    • 13
    • 11
    • 9
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Dieser PD-L1 Antikörper ist unkonjugiert
    Applikation
    • 135
    • 101
    • 56
    • 40
    • 37
    • 27
    • 16
    • 16
    • 14
    • 14
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (fixed cells) (IF/ICC), Multiplex Immunofluorescence (mIF)
    Verwendungszweck
    Rabbit anti-PD-L1 Recombinant Monoclonal Antibody [BLR020E]
    Immunogen
    between AA 250 to 290 (C-term)
    Klon
    BLR020E
    Isotyp
    IgG
    Top Product
    Discover our top product PD-L1 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1000 μg/mL
    Buffer
    Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Haltbarkeit
    12 months
  • Target
    PD-L1 (CD274 (PD-L1))
    Andere Bezeichnung
    PD-L1 (PD-L1 Produkte)
    Synonyme
    B7-H antikoerper, B7H1 antikoerper, PD-L1 antikoerper, PDCD1L1 antikoerper, PDCD1LG1 antikoerper, PDL1 antikoerper, A530045L16Rik antikoerper, B7h1 antikoerper, Pdcd1l1 antikoerper, Pdcd1lg1 antikoerper, Pdl1 antikoerper, RGD1566211 antikoerper, CD274 molecule antikoerper, CD274 antigen antikoerper, programmed cell death 1 ligand 2 antikoerper, CD274 antikoerper, Cd274 antikoerper, PDCD1LG2 antikoerper
    Hintergrund
    Background: PD-L1 is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. PD-L1 is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma [taken from NCBI Entrez Gene (Gene ID: 55193)].
    Gen-ID
    29126
    NCBI Accession
    NP_054862
    UniProt
    Q9NZQ7
    Pathways
    Cancer Immune Checkpoints
Sie sind hier: